Stanford researchers at the Thakor Lab have developed methods for kidney tissue regeneration using pulsed focused ultrasound (pFUS) therapy with mesenchymal stromal cells (MSCs) and/or MSC-derived extracellular vesicles (e.g., exosomes or microvesicles).
The emergence of SARS-CoV-2 variants during the COVID-19 pandemic has demonstrated a need for broad immunization, such as provided by multivalent vaccines.
Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
Researchers in the Stanford University Power Electronics Research Lab have designed an easy to implement, high-efficiency, high-frequency power amplifier with low voltage stress.
As of 2020, radiation therapy has saved over 3.38 million cancer patients in the US. Radiation therapy treatment planning often involves a time-consuming and labor-intensive process where physicians must manually optimize the prescribed radiation dose.
Researchers in the Stanford Robotics Lab have developed a compact high-fidelity haptic teleoperation system which shows accurate and isotropic behavior in translation and rotation.
A Stanford University physician has developed a device to stimulate regeneration of olfactory nerves using minimally invasive electrical neurostimulation.
This invention involved a new methodology using novel targets, TMS stimulation and a hypnosis protocol to modulate traits and help chronic pain, addiction, and mental disorders.
Doctors with Stanford Medicine have developed a multi-user, mixed reality medical simulation application. Medical in-situ and simulation training centers cost millions of dollars a year to administer, with limited availability to those in remote areas or the third world.
Stanford researchers are developing an improved prophylactic against pancreatitis caused by endoscopic retrograde cholangiopancreatography (ERCP), by targeting two key inflammatory pathways.
Stanford researchers have applied large-scale proteomic platforms to identify biomarkers that can be used to diagnose uveal melanoma and subtype eye tumors according to their gene expression profile (GEP) class or PRAME status.
Researchers in the Nakauchi lab at Stanford University have shown that the contribution of human donor cells to tissues and organs can be increased in an interspecies host embryo by knocking out insulin growth factor 1 receptor (Igf1r).
A team of researchers at Stanford have developed a hydrogel that delivers a scar-reducing focal adhesion kinase inhibitor (FAK-I) to skin grafts and donor sites.
Acute and end stage renal disease affects patients across all ages. Pediatric patients are usually treated with hemodialysis, which requires them to be surgically implanted with a central venous catheter (CVC) for dialysis access.